Strata Critical Medical (SRTA) Operating Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has reported Operating Expenses for 8 consecutive years, with $17.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses rose 34.17% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $64.9 million (up 6.38% YoY), while the FY2025 annual figure was $63.5 million, up 21.81% from the prior year.
• Operating Expenses improved to $17.1 million in Q1 2026 per SRTA's latest filing, from -$82.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $83.1 million in Q4 2023 and bottomed at -$82.8 million in Q4 2025.
• Historically, Operating Expenses has averaged $34.5 million across 5 years, with a median of $54.9 million in 2025.
• Annual changes were most pronounced in 2023 — Operating Expenses surged 768.1% — and 2024, when it slumped 190.16%.
• Strata Critical Medical's Operating Expenses stood at $45.4 million in 2022, then surged by 83.2% to $83.1 million in 2023, then plunged by 190.16% to -$74.9 million in 2024, then dropped by 10.52% to -$82.8 million in 2025, then soared by 120.64% to $17.1 million in 2026.
• Business Quant data shows SRTA's Operating Expenses at $17.1 million in Q1 2026, -$82.8 million in Q4 2025, and $54.9 million in Q3 2025.